Seapine Software - FDA Design Traceability Requirements for Device Development | Media

Seapine Software - FDA Design Traceability Requirements for Device Development

Posted Date: 12/15/2011

This is a recording of Seapine's webinar on FDA Design Traceability Requirements for Device Development with John Avellanet, Managing Director & Principal at Cerulean Associates, LLC, and Larry Nicholson, Business Development Manager for Life Sciences at Seapine Software. Additionally, you download the FDA Expectations for Traceability in Device Design slide deck and view the Q&A on our blog. View Now

Comments:

Be the first to leave a comment.

Post your comments about this article or questions for the author here

CAPTCHA Validation

Code:

* Name:
* Email:

The QA/ RA Cheat Sheet

Emerging Markets: Maximize Opportunity, Minimize Risk

America Invents Act – How Will It Affect You?

Does Device Manufacturing Need Cleanrooms?

Medical Device Vendors Need a New Mix of Field Resources

Has “Open Season” on Infringement of Medical Device Patents Begun?

Asian Tigers: Vietnam Device Industry Overview

Device Cures Diabetes, Obesity in 15 minutes, Without Surgery

Is Nintendo the next Medtronic?

Guidant Pleads Guilty in 2005 ICD Recall Case

Will FDA Scrap the 510(k)?

Restructuring on Full Steam at Boston Scientific

Shuren Gets a Earful

Boston Scientific 2Q Profit Falls; Mixed Results from J&J; Good Year for Medtronic CEO

This is top-emailed stories

MEDdesign: What Can Color, Material and Trends Forecasting Do For Medical Devices?

When it comes to understanding which colors to choose, how to apply color and why, and what kinds of materials and surface finish create the most value, design expertise and direction is required. It’s time to make medical products object of desire rather than disinclination.